Previous Page  6 / 7 Next Page
Information
Show Menu
Previous Page 6 / 7 Next Page
Page Background

Formulation R&D |

Pre-Formulation Studies | Pharmaceutical Formulations

JULY 19, 2019

DAY 2 SESSIONS

SESSION INTRODUCTION

Title:

Ultra performance liquid chromatographic method development and validation for the determination of

Glecaprevir and Pibrentasvir in pharmaceutical dosage forms

Poojitha Dhulipalla,

Vimta Labs Ltd., India

SESSION CHAIR

Adam Frosh

Lister Hospital, United Kingdom

Pharma Summit 2019